Physician profile
Kayvon Ameri
NPI 1316583412
$2,508.75
in general payments reported to CMS, 2019-2025
11 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $772 · 2023: $564 · 2024: $501 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522 · Travel and Lodging: $73.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.84 |
| Travel and Lodging | $73.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,808.09 | 2022-2025 | Mako |
| Depuy Synthes Sales INC. | $269.36 | 2022 | |
| Bioventus LLC | $169.45 | 2021-2022 | |
| Seapearl East, INC | $110.20 | 2025 | |
| Sanara Medtech INC. | $35.97 | 2025 | Celleraterx |
| Medtronic, INC. | $28.39 | 2023 | Medtronic Reusable Instruments |
| Ferring Pharmaceuticals INC. | $23.18 | 2025 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $18.71 | 2023 | |
| Ermi LLC | $16.60 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.40 | 2023 | Xtampza |
| Horizon Therapeutics Plc | $14.40 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayvon Ameri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.